drugset / Trial / NCT00663728

Assessment of Duration of Erection With Vardenafil 10 mg

NCT00663728

Phase 4 Completed 201 enrolled Bayer GlaxoSmithKline · collab
RandomizedCrossoverDouble-blindTreatment

Summary

This study assessed the effect of 10mg vardenafil, taken on demand in an 'at home' setting, as compared to placebo (dummy medication with no pharmacological activity), on the duration of erection from the moment when the patient perceived his erection to be hard enough for penetration until withdrawal from the partner's vagina leading to successful completion which may or may not have included ejaculation. The patient used the stopwatch for the above assessments. The efficacy of oral ED treatments is measured by questionnaires and patient diaries.

Timeline

Start
2004-09
Primary completion
2005-04
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Vardenafil Small molecule 10 mg Oral

Indications